Kenalog Injection 40 mg Multiple-Dose Vial 10 mL (Rx)

Kenalog injection is a form of triamcinolone, a synthetic corticosteroid hormone. It is primarily used to treat inflammation and pain caused by a variety of conditions, including arthritis, allergic reactions, skin disorders, and various types of joint pain (such as bursitis and tennis elbow). Kenalog injection may also be used to treat certain eye conditions and certain types of cancer. Kenalog injection works by suppressing the body's immune response and reducing inflammation, thereby providing relief from symptoms. It is usually given by a healthcare professional in a doctor's office or clinic setting.

Bristol Myers Squibb Kenalog Injection (triamcinolone acetonide) is a steroid injected into the joint space to treat inflammation of the joints or tendons to treat arthritis, bursitis, or epicondylitis (tennis elbow). Kenalog is usually given in these conditions as a short-term treatment of a severe or aggravated episode.

Benefits of Kenalog 40 for Injection

• Reduces inflammation by decreasing the activity of the immune system
• Efficiently treats a variety of medical conditions affecting the skin, joints and muscles
• Is fast-acting with temporary relief
• Can be used in conjunction with other treatments, such as physical therapy treatments
• Reduces both chronic and short-term inflammatory conditions
• May help improve the healing process in severe conditions
• Cost-effective when compared to traditional options for treating inflammation
• Can be used for long-term maintenance therapy
• Easy-to-store solution
• Non-intoxicating and does not alter physical or mental performance

Cortisone injections can be used to treat inflammation of small areas of the body, such as inflammation of a specific joint or tendon. They can also treat inflammation that is widespread throughout the body, such as with allergic reactions, asthma, and rheumatoid arthritis, which affects many joints.

Instructions on How to Administer Kenalog 40 for Injection 10 mL

• Wash your hands with soap and water.
• Assemble a clean needle and syringe.
• Remove Kenalog 40 from the refrigerator and let it warm up to room temperature before using for about 30 minutes.
• Check the vial to make sure it has no cracks, flakes, or other defects.
• Clean the top of the vial with an alcohol swab.
• Draw the prescribed amount of Kenalog 40 into the syringe.
• Remove air bubbles from the syringe using the plunger.
• Disinfect the injection site with an alcohol swab.
• Insert the needle into the skin at a 90-degree angle.
• Empty the contents of the syringe slowly and steadily.
• Remove the needle from the injection site and cover with a cotton wool pad.
• Place the used needles and syringe into a sharp container.
• Cover the injection site with a bandage if desired.
• Dispose of the container in an appropriate medical waste receptacle.

Specifications:

Size: 10 mL
NDC: 00003-0293-28
UPC: 300030293282

Brand: Bristol Myers Squibb

Uses and Applications

Kenalog 40 mg/mL Injection is indicated for:

• Rheumatoid Arthritis & Osteoarthritis – For relief of acute or chronic joint inflammation through intra-articular or intramuscular injection.
• Allergic Disorders – Controls severe allergic reactions and asthma exacerbations.
• Dermatologic Conditions – Effective for treating eczema, psoriasis, keloids, lichen planus, and dermatitis.
• Systemic Corticosteroid Therapy – For endocrine, gastrointestinal, hematologic, and respiratory conditions requiring corticosteroid treatment.
• Lupus, Bursitis, Tendonitis – Provides anti-inflammatory action and rapid symptom relief.
• Gout Flares and Other Inflammatory Conditions

Benefits & Features

• Powerful Anti-Inflammatory Action – Quickly reduces swelling, redness, and pain.
• Long-Lasting Relief – Single injection can provide sustained symptom relief.
• Versatile Use – Suitable for intramuscular, intra-articular, intralesional, and soft tissue injection.
• Multiple-Dose Vial – 10 mL multidose design for hospital and clinic efficiency.
• Trusted Manufacturer – Bristol Myers Squibb guarantees quality, purity, and safety.

Instructions for Use

1. Preparation

• Wash your hands thoroughly with soap and water before handling the vial or syringe.
• Gather all necessary supplies: Kenalog vial, syringe and needle (as directed), alcohol swab, clean gauze or cotton ball, and a sharps disposal container.
• Inspect the vial: Check the expiration date and ensure the solution is not cloudy, discolored, or contains particles. If it is, do not use it—contact your pharmacist.
• Mix the suspension: Roll the vial gently between your hands to mix. Do not shake vigorously.

2. Drawing up the Dose

• Clean the rubber stopper of the Kenalog vial with an alcohol swab.
• Attach a new sterile needle to the syringe.
• Draw air into the syringe equal to your prescribed dose.
• Insert the needle into the vial and inject air to make withdrawing the medication easier.
• Invert the vial and withdraw the exact prescribed dose.
• Remove the needle, check for air bubbles, and tap out any bubbles.

3. Injection Procedure

(Your doctor will tell you whether to inject into a muscle (intramuscular), under the skin (intra-articular, intralesional, etc.), or for another specific use.)

• Intramuscular (IM) Injection:
  • Choose a large muscle (such as upper outer quadrant of the buttocks).
  • Clean the area with an alcohol swab.
  • Insert the needle at a 90-degree angle.
  • Inject the medication slowly.
  • Withdraw the needle and apply gentle pressure with gauze.
• Intra-articular/Intralesional/Other Routes:
  • These are usually performed by a healthcare professional. Do not self-administer by these routes unless your doctor has specifically trained you.

4. After Injection

• Dispose of the syringe and needle in a sharps container.
• Store the remaining vial as directed: at room temperature, not in the fridge or freezer, and protected from light.

5. Frequency and Dose

• Follow your healthcare provider’s prescription carefully.
• Typical dosing varies based on condition, age, and weight.
• Do not exceed the prescribed dose or frequency.

Important Precautions

• Do not use if you are allergic to triamcinolone or other corticosteroids.
• Kenalog injections should only be administered by or under the instruction of a healthcare provider.
• Do not inject into a vein unless a healthcare provider directs and trains you.
• Do not use if you have a fungal, viral, or bacterial infection unless approved by your doctor.
• Monitor for side effects: infection at the site, pain, swelling, allergic reactions, hormone changes, etc.
• Inform your doctor if you are pregnant, breastfeeding, or have other medical conditions (e.g., diabetes, hypertension, osteoporosis).
• Store out of reach of children.

NEVER share your vial, syringes, or needles with anyone else.

General Dosage and Administration Guidelines

Always follow your healthcare provider’s specific instructions for dosing and administration.

1. Preparation

• Shake or roll the vial gently before drawing up the dose—do not inject any solution that appears discolored or contains particles.

2. Routes of Administration

Kenalog-40 may be administered:

• Intramuscularly (IM)
• Intra-articularly (in a joint)
• Intralesionally (into skin lesions)
• Soft Tissue Injection

Do NOT inject intravenously (IV) or use for spinal administration.

3. Typical Adult Dosage by Indication & Route

A. Intramuscular (Systemic Use)

• Adults:
  • Dose: 40–80 mg (1–2 mL) IM deep in the gluteal muscle
  • Frequency: May be repeated weekly, biweekly, or less frequently, depending on the clinical response

B. Intra-articular (Joint) Injection

• Large Joints (Knee, Shoulder, Hip):
  • Dose: 20–40 mg (0.5–1 mL)
• Small Joints (Wrist, Elbow, Ankle):
  • Dose: 10–20 mg (0.25–0.5 mL)
• Repeat as needed, usually every 3–4 weeks, but as directed by the doctor.

C. Intralesional Injection

• Dose: 2–20 mg per injection site (0.05–0.5 mL), depending on the size of lesion
• Repeat at intervals as necessary based on condition and response

D. Soft Tissue Injection

• Dose: 10–40 mg (0.25–1 mL)

4. Pediatric Dosage

• Dosage is adjusted by condition, child’s age, and weight.
• Children are more susceptible to side effects; use the lowest effective dose.

5. Administration Instructions

• Use aseptic technique.
• For IM use, inject deep into the gluteal muscle (NOT deltoid).
• For intra-articular or intralesional use, should be performed by or under the supervision of a qualified physician.
• After withdrawing the dose, inject promptly.

WARNINGS AND PRECAUTIONS

• Do not inject into the deltoid muscle, as this may cause subcutaneous atrophy.
• Do not use in patients with systemic fungal infections.
• Injection should be given by a healthcare provider, especially for intra-articular and intralesional routes.
• Long-term systemic use requires close medical supervision.

Dose Frequency and Adjustment

• Dosage and frequency depend on the patient’s response and the disease being treated.
• The physician will adjust the dose as necessary to achieve the desired therapeutic response with the lowest effective dose.

Missed Dose

• If you miss a dose, contact your healthcare provider for instructions. Do not double the dose.

Storage

• Store at room temperature; do not freeze. Protect from light.

Drug Interactions

• Drug classes to monitor:
  • NSAIDs: Increased risk of gastrointestinal bleeding/ulcers.
  • Live vaccines: Reduced vaccine efficacy and increased infection risk.
  • Diabetic medications: May require dose adjustment due to hyperglycemia risk.
  • Potassium-depleting agents (e.g., diuretics): Increased risk of hypokalemia.
  • Other immunosuppressants: Enhanced immunosuppression.

Consult prescribing information for a comprehensive list of interactions.

Side Effects & Warnings

Most Common Side Effects

• Local pain, redness, or swelling at injection site
• Mood changes, sleep disturbances
• Weight gain, increased appetite
• Elevated blood glucose
• Fluid retention and swelling

Serious Adverse Reactions

• Suppression of adrenal gland function
• Infection risk increase
• Allergic reactions: Rash, itching, or anaphylaxis
• Muscle weakness, osteoporosis (with repeated use)
• Cataracts or glaucoma (with prolonged use)
• Gastrointestinal bleeding or ulcers

Warnings & Precautions

• Not for intravenous use.
• Use with caution in patients with diabetes, hypertension, heart failure, peptic ulcer, and active infections.
• May mask symptoms of infection; monitor closely.
• Taper dose gradually if discontinuing after prolonged use.
• Not recommended in active untreated systemic infections.
• Use during pregnancy/lactation: Benefit vs. risk assessment required.

Order Kenalog Injection 40mg 10mL by Bristol Myers Squibb Today

NDC: 00003-0293-28 | UPC: 300030293282 | Fast Shipping | 100% Authentic | Trusted Source

• Product: Kenalog Injection 40 mg/mL — triamcinolone acetonide injectable suspension (Rx only)
• Format: 10 mL multiple-dose vial — supports multiple administrations per vial for high-volume clinical settings
• Manufacturer: Bristol Myers Squibb — brand-name product supplied as manufactured
• Primary use cases: Intra-articular corticosteroid injection for arthritis, bursitis, and epicondylitis; intramuscular use for severe allergic reactions and systemic inflammatory conditions
• Concentration: 40 mg/mL — the higher-strength Kenalog formulation, distinct from Kenalog-10 (10 mg/mL), which is indicated for intradermal applications
• Wholesale availability: Available to verified, licensed healthcare professionals and institutional buyers through Mountainside Medical; free US shipping on orders over $100
• New account benefit: 5% off first purchase — applicable to qualifying licensed buyer accounts

• Arthritis management: Intended to support intra-articular injection for rheumatoid arthritis and osteoarthritis flares, providing short-term inflammatory control in affected joints
• Bursitis and epicondylitis: Designed for use in bursal injections and soft-tissue injections for epicondylitis (tennis elbow) — typically administered as a short-term treatment of a severe or aggravated episode
• Systemic inflammatory and allergic conditions: Intended for intramuscular use in managing severe allergic reactions and widespread inflammatory conditions including certain asthma presentations and rheumatoid arthritis affecting multiple joints
• Adjunct to physical therapy: May be used in conjunction with physical therapy and other treatment modalities as part of a broader inflammatory management protocol — not as a standalone long-term therapy
• Applicable clinical settings: Orthopaedic clinics, rheumatology and sports medicine practices, primary care offices, emergency medicine, and EMS — any licensed setting requiring a reliable long-acting steroid injection
• Dosage reference: Cortisone injection dosage for adults varies by indication and injection site; prescribing clinicians should reference the Bristol Myers Squibb Kenalog-40 prescribing information and FDA-approved labelling for current dosing guidance

• Rx-only product: Kenalog Injection 40 mg/mL is a prescription-only corticosteroid injectable. It must be administered by or under the direct supervision of a licensed healthcare professional.
• Contraindications: Per FDA-approved prescribing information, triamcinolone acetonide injection is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any component of the formulation, and in patients with systemic fungal infections.^[3]
• Immunosuppression risk: Corticosteroids suppress immune response; use with caution in patients with active infections, latent tuberculosis, or known immunocompromised status. Clinicians should evaluate infection risk prior to administration.
• Concentration-specific precaution: The 40 mg/mL formulation is not intended for intradermal injection — intradermal administration of high-concentration triamcinolone acetonide carries a documented risk of localised skin atrophy and depigmentation.^[2]
• Pregnancy and special populations: Consult current FDA prescribing information for guidance on use during pregnancy, lactation, and in paediatric populations. Not specified further in provided data.
• Vial inspection required: Each vial must be visually inspected for particulate matter, discolouration, or physical defects before use. Do not use a compromised vial.
• Sharps disposal: All used needles, syringes, and vials must be disposed of in an approved sharps container and medical waste receptacle in compliance with applicable local, state, and federal regulations.

• Prescription requirement: Kenalog Injection 40 mg/mL is an Rx-only product. All orders require verification of a valid medical licence or institutional purchasing credentials before fulfilment.
• Who can order: Available to clinics, hospitals, physicians' offices, EMS teams, dental and veterinary practices, medspas, and other licensed healthcare facilities and institutional buyers purchasing in bulk across the United States.
• Wholesale pricing: Corticosteroid injection price is structured for wholesale and bulk procurement — volume savings are available for qualifying orders. Contact the sales team for institutional pricing details.
• Free shipping threshold: Free US shipping on orders over $100. Standard US-wide delivery applies.
• New account discount: First-time buyers receive 5% off their first qualifying purchase.
• Contact for procurement: Reach the Mountainside Medical sales team at sales@mountainside-medical.com or +1 (888) 687-4334 for bulk order enquiries, formulary documentation, or NDC verification (NDC: 00003-0293-28).

• What is Kenalog Injection 40 mg used for?

  Kenalog Injection 40 mg/mL (triamcinolone acetonide) is a corticosteroid injectable intended to support the management of inflammatory conditions including arthritis, bursitis, epicondylitis (tennis elbow), and severe allergic reactions. It is administered by intra-articular, intramuscular, or soft-tissue injection by a licensed healthcare professional. This product is not intended for self-administration or consumer use.

• Is Kenalog 40 the same as triamcinolone acetonide?

  Yes. Kenalog is the brand name for triamcinolone acetonide injectable suspension, manufactured by Bristol Myers Squibb. The 40 mg/mL formulation (Kenalog-40) is a synthetic glucocorticoid corticosteroid. Generic triamcinolone acetonide formulations at equivalent concentrations exist, but this listing supplies the branded Kenalog product under NDC: 00003-0293-28.

• What is the difference between Kenalog 40 and Kenalog 10?

  The primary difference is concentration and intended injection route. Kenalog 40 contains triamcinolone acetonide at 40 mg/mL and is designed for intra-articular, intramuscular, and larger soft-tissue injections. Kenalog 10 (10 mg/mL) is formulated for intradermal and smaller soft-tissue applications. Administering the 40 mg/mL formulation via the intradermal route is not appropriate and carries risk of localised skin atrophy, per FDA prescribing guidance.

• What is the cortisone injection dosage for adults using Kenalog 40?

  Cortisone injection dosage for adults using Kenalog 40 varies by injection site and clinical indication. Per FDA-approved prescribing information, intra-articular doses for large joints typically range from 5 mg to 15 mg, while larger soft-tissue sites may require up to 40 mg. Dosing decisions must be made by the treating clinician based on the patient's condition, response to treatment, and current prescribing guidelines.

• How long does a Kenalog injection last?

  The duration of effect for a Kenalog steroid injection varies by patient, indication, and injection site. Clinical evidence indicates that intra-articular corticosteroid injections may provide meaningful short-term pain relief measurable at one to two weeks post-injection, with effects typically lasting several weeks in musculoskeletal applications. Individual response varies and long-term use is generally managed as part of a broader treatment protocol by the prescribing clinician.

• Who can purchase Kenalog Injection 40 mg through Mountainside Medical?

  Kenalog Injection 40 mg/mL is an Rx-only product available exclusively to verified, licensed healthcare professionals and institutional buyers. Eligible purchasers include physicians, clinics, hospitals, EMS teams, dental and veterinary practices, medspas, and similar licensed healthcare entities. A valid medical licence or institutional purchasing credential is required for order fulfilment.

• What is the NDC for Kenalog Injection 40 mg 10 mL?

  The NDC (National Drug Code) for Kenalog Injection 40 mg/mL 10 mL multiple-dose vial by Bristol Myers Squibb is 00003-0293-28. The UPC is 300030293282. These identifiers can be used for formulary matching, billing reference, and procurement documentation.

• What are the contraindications for injectable corticosteroids like Kenalog?

  Per FDA-approved prescribing information, Kenalog Injection (triamcinolone acetonide) is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any component of the formulation, and in patients with systemic fungal infections. Additional caution is required in patients with active infections, latent tuberculosis, immunocompromised status, and certain other conditions. Prescribing clinicians should review the full Bristol Myers Squibb prescribing information before use.

• Does Mountainside Medical offer wholesale pricing on corticosteroid injections?

  Yes. Mountainside Medical supplies Kenalog Injection 40 mg/mL and other injectable corticosteroids at wholesale pricing for licensed buyers. Free US shipping applies on orders over $100. New accounts receive 5% off their first purchase. For bulk order pricing and institutional procurement enquiries, contact the sales team at sales@mountainside-medical.com or +1 (888) 687-4334.